Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Sayre

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|September 30, 1987
Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a "redox cycling" mechanism in MPTP neurotoxicityD M Frank, P K Arora, J L Blumer, et al.
Archives of Biochemistry and Biophysics|April 1, 1991
Inhibition of mitochondrial respiration by neutral, monocationic, and dicationic bis-pyridines related to the dopaminergic neurotoxin 1-methyl-4-phenylpyridinium cation (MPP+)M P Singh, F J Wang, C L Hoppel, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|June 1, 1997
Effect of methimazole, an FMO substrate and competitive inhibitor, on the neurotoxicity of 3,3'-iminodipropionitrile in male ratsC G Nace, M B Genter, L M Sayre, et al.
Chemical Research in Toxicology|January 1, 1993
Pyrrole formation from 4-hydroxynonenal and primary aminesL M Sayre, P K Arora, R S Iyer, et al.
Molecular Toxicology|January 1, 1987
beta,beta'-Iminodipropionitrile (IDPN) neurotoxicity: a mechanistic hypothesis for toxic activationA R Jacobson, S H Coffin, C M Shearson, et al.
Journal of Neurochemistry|April 1, 1988
Potent neurotoxic fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs as potential probes in models of Parkinson diseaseN J Riachi, P K Arora, L M Sayre, et al.
Journal of Medicinal Chemistry|October 1, 1984
Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissuesL M Sayre, D L Larson, A E Takemori, et al.
Biochemical and Biophysical Research Communications|May 16, 1988
Chemical oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its in vivo metabolism in rat brain and liverP K Arora, N J Riachi, S I Harik, et al.
Toxicology and Applied Pharmacology|June 15, 1986
Structural basis of gamma-diketone neurotoxicity: non-neurotoxicity of 3,3-dimethyl-2,5-hexanedione, a gamma-diketone incapable of pyrrole formationL M Sayre, C M Shearson, T Wongmongkolrit, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1988
On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liverN J Riachi, S I Harik, R N Kalaria, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|September 30, 1987
Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a "redox cycling" mechanism in MPTP neurotoxicityD M Frank, P K Arora, J L Blumer, et al.
Archives of Biochemistry and Biophysics|April 1, 1991
Inhibition of mitochondrial respiration by neutral, monocationic, and dicationic bis-pyridines related to the dopaminergic neurotoxin 1-methyl-4-phenylpyridinium cation (MPP+)M P Singh, F J Wang, C L Hoppel, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|June 1, 1997
Effect of methimazole, an FMO substrate and competitive inhibitor, on the neurotoxicity of 3,3'-iminodipropionitrile in male ratsC G Nace, M B Genter, L M Sayre, et al.
Chemical Research in Toxicology|January 1, 1993
Pyrrole formation from 4-hydroxynonenal and primary aminesL M Sayre, P K Arora, R S Iyer, et al.
Molecular Toxicology|January 1, 1987
beta,beta'-Iminodipropionitrile (IDPN) neurotoxicity: a mechanistic hypothesis for toxic activationA R Jacobson, S H Coffin, C M Shearson, et al.
Journal of Neurochemistry|April 1, 1988
Potent neurotoxic fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs as potential probes in models of Parkinson diseaseN J Riachi, P K Arora, L M Sayre, et al.
Journal of Medicinal Chemistry|October 1, 1984
Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissuesL M Sayre, D L Larson, A E Takemori, et al.
Biochemical and Biophysical Research Communications|May 16, 1988
Chemical oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its in vivo metabolism in rat brain and liverP K Arora, N J Riachi, S I Harik, et al.
Toxicology and Applied Pharmacology|June 15, 1986
Structural basis of gamma-diketone neurotoxicity: non-neurotoxicity of 3,3-dimethyl-2,5-hexanedione, a gamma-diketone incapable of pyrrole formationL M Sayre, C M Shearson, T Wongmongkolrit, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1988
On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liverN J Riachi, S I Harik, R N Kalaria, et al.
Pageof 8